Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Drug Allergy
Are you using any AI models to de-label penicillin allergy?
Related Questions
What medications would you have a patient avoid with an IgE mediated reaction to cyclobenzaprine?
Do you recommend desensitization to biologics since this has to occur repeatedly?
Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?
Do you believe that pretreatment with montelukast or other LTRAs can reduce the risk of urticaria or angioedema with NSAIDS?
Is omalizumab an option for a patient needing a specific antibiotic with an IgE-mediated reaction who continues to have reactions during a desensitization?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
Would you consider rechallenging immunotherapy if the first dose was accompanied with an acute infusion reaction with low back pain, shortness of breath and chest pain which resolved with monitoring, and subsequent cardiac workup being negative?
Are there specific conventional DMARDs and/or biologics that are contraindicated in patients with alpha-gal allergy?
In those patients who are initiated on omalizumab for multiple food allergies, how long should you wait before performing baked egg and baked milk challenges?
Do you retest for environmental aeroallergens when patients have relocated within the US between vastly different climates?
